Immunocore Holdings Plc (IMCR) Hits 52-Week Low Despite 34% Surge in KIMMTRAK Sales
Barclays Gives a Buy Rating to Immunocore Holdings (IMCR)
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
A Quick Look at Today's Ratings for Immunocore(IMCR.US), With a Forecast Between $78 to $100
Immunocore Hldgs Analyst Ratings
TD Cowen Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $90
Capital One Financial Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $90
Immunocore Presents Phase 1 Data of Brenetafusp, an ImmTAC Bispecific Targeting PRAME, in Patients With Ovarian Cancer
Is Immunocore Holdings (NASDAQ:IMCR) Using Debt In A Risky Way?
Immunocore to Present at the 2024 Cantor Global Healthcare Conference
Mizuho Securities Maintains Immunocore(IMCR.US) With Buy Rating, Announces Target Price $72
Buy Rating Affirmed for Immunocore Holdings on Promising Brenetafusp Prospects and Strong Company Fundamentals
Barclays Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $66
Immunocore Holdings Plc (IMCR): Top ADR Stock According to Hedge Funds
Immunocore CFO to Leave Company
Immunocore Holdings: Di Donato Has Accepted New CEO at a Private, Early-Stage Biotech >IMCR
Express News | Immunocore Holdings PLC - CFO Brian Di Donato to Leave End of Year
Express News | Immunocore Announces Transition of Chief Financial Officer
The Latest Analyst Ratings For Immunocore Hldgs
H.C. Wainwright Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $100